Pharmacy Enterprise (CUPE) เมื่อวันที่ 18 ธันวาคม 2563 ณ อาคารนวัตกรรมทางเภสัชศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย
and would be completed in the similar time periods. This caused work overload and shortage of skilled workers Q4/2018 and into Q1/2019, resulting on cost overrun. Discussion and Analysis of the Company
at a lower fee. This is a temporary measure to promote more entries of knowledgeable and skilled auditors into the capital market. Interested auditors are welcome to apply for approval as capital
regulations specified by the SEC and arrange for IT security audit and a penetration test by a knowledgeable and skilled auditor who is independent from the responsible IT Unit before commencing service
Miss Rae- vadee T. Suwan , a Audit Director 0.09% shared held 5.3 Mrs. Kannika Chatmahakulchai 0.03% shares held as a Director of Pharmacy department. 5.4 Mr. Viroj Noragrai none % shares held as the
started and would be completed in the similar time periods. This caused work overload and shortage of skilled workers Q4/2018 and into Q1/2019, resulting on cost overrun. And another reason is a one-time
represents increasing of loss 69 million Baht from Q2/2018’s profit of 7 million Baht. One reason for net loss is because of the work overload and shortage of skilled workers which started in Q1/2019 but with
oil and gas productions, utilizing strict quality and safety standards of the offshore industry. The Company has been provided skilled technical personnel to work on both onshore and offshore facilities
independent pharmacy channel, totaling approximately 4.99 million baht which increased by 2.24 million baht year-on-year due to increased sales. Some expenses have dropped i. e. sales promotion expenses, booth